VANCOUVER, British Columbia, Feb. 7, 2019 /PRNewswire/ -- Crop
Infrastructure Corp. (CSE: CROP) (OTC: CRXPF) (Frankfurt: 2FR) announced today its
Washington State tenant's first crops have had successful test results.
The samples showed a range of Tetrahydrocannabolic Acid ('THCA') results and passed all tests for microbial impurities and no
detectable pesticides. THCA is not directly used, but its presence is commonly analyzed when cannabis, or hemp-based products,
are screened for THC. The tenant is now approved to begin selling the products in the Washington
State market.
STRAIN
|
THCA
|
9 LB Hammer
|
26.65%
|
Woo
|
19.47%
|
Dutch Hawaiian
|
22.54%
|
Bubba Kush
|
27.35%
|
Gorilla Glue
|
18.16%
|
Green Crack
|
17%
|
Star Killer
|
26.99%
|
Ghost Train
|
16.02%
|
Dutch Treat (Distillate)
|
79.1% THC 12.31% CBD
|
The tenant is working with both bulk extraction buyers as well as retail locations under the Hempire and Evolution brands in
the Washington market.
CROP CEO, Michael Yorke, stated: "This is an excellent result and certainly bodes well for
the future. CROP's tenant production teams continue to show what meticulous controls, defined production protocols and a focus on
organic operations can mean in terms of resulting products."
About CROP
CROP is publicly listed on the CSE and trades under the symbol "CROP". CROP is focused on cannabis branding and real estate
assets. CROP's portfolio of projects includes cultivation properties in California, two in
Washington State, a 1,000-acre Nevada Cannabis farm, 1,865 acres of CBD farms, extraction in
Nevada and joint ventures on West Hollywood and San Bernardino dispensary apps with international focuses in Jamaica and
Italy.
CROP has developed a portfolio of assets including Canna Drink, a cannabis infused functional beverage line, US and Italian
distribution rights to over 55 cannabis topical products and a portfolio of 16 Cannabis brands. CROP's infrastructure has
over 150,000 sq ft of built canopy and over 2,900 acres of real estate.
Disclaimer for Forward-Looking Information
Certain statements in this press release are forward-looking statements are not based on historical facts, but rather on
current expectations and projections about future events and are therefore subject to risks and uncertainties which could cause
actual results to differ materially from the future results expressed or implied by the forward-looking statements. In addition,
marijuana remains a Schedule I drug under the United States Controlled Substances Act of 1970. Although Congress has prohibited
the US Justice Department from spending federal funds to interfere with the implementation of state medical marijuana laws, this
prohibition must be renewed each year to remain in effect. These statements generally can be identified by the use of
forward-looking words such as "may", "should", "could", "intend", "estimate", "plan", "anticipate", "expect", "believe" or
"continue", or the negative thereof or similar variations. Forward-looking statements in this news release include statements
regarding the expected returns from the California Project; the technological effects of California Project; the intention to
expand its portfolio; and execute on its business plan. Such statements are qualified in their entirety by the inherent risks and
uncertainties surrounding the regulatory and legal framework regarding the cannabis industry in general among all levels of
government and zoning; risks associated with applicable securities laws and stock exchange rules relating to the cannabis
industry; risks associated with maintaining its interests in its various assets; the ability of the Company to finance operations
and execute its business plan and other factors beyond the control of the Company. Such forward-looking statements should
therefore be construed in light of such factors, and the Company is not under any obligation, and expressly disclaims any
intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future
events or otherwise, except as required by applicable law.
The CSE has not reviewed, approved or disapproved the content of this press release.
Company Contact
Michael Yorke – CEO and Director
E-mail: info@cropcorp.com
Website: www.cropcorp.com
Phone: +1(604) 484-4206